Becker-Bense, Sandra http://orcid.org/0000-0001-9214-3583
Kaiser, Lena
Becker, Regina
Feil, Katharina
Muth, Carolin
Albert, Nathalie L.
Unterrainer, Marcus
Bartenstein, Peter
Strupp, Michael
Dieterich, Marianne
Funding for this research was provided by:
Bundesministerium für Bildung und Forschung (01 EO 0901, 01 EO 1404)
Deutsche Forschungsgemeinschaft (EXC 2145 SyNergy, ID 390857198)
Deutsche Stiftung Neurologie (not kownn)
Universitätsklinik München
Article History
Received: 19 February 2022
Revised: 27 May 2022
Accepted: 20 June 2022
First Online: 25 July 2022
Declarations
:
: On behalf of all authors, the corresponding author states that there is no conflict of interest. Prof. Strupp reported being the joint chief editor of the Journal of Neurology, editor in chief of Frontiers of Neuro-otology, and section editor of F1000. He also reported receiving speaker’s honoraria from Abbott, Actelion, Auris Medical, Biogen, Eisai GmbH, Grünenthal, GlaxoSmithKline, Hennig Pharma, Interacoustics, MSD Sharp & Dohme, Mylan, Otometrics, Pierre Fabre, TEVA GmbH, and UCB SA Belgium; and being a paid consultant for Abbott, Actelion, AurisMedical, Heel, IntraBio, and Sensorion. He is an investor and shareholder in IntraBio as well as the distributor of Mglasses and the Positional Vertigo App. He has reported receiving grants for research for Decibel, Heel Pharma, and Hennig Pharma.
: The study protocol was approved by the Ethics Committee of the University of Munich (21-0166) and was conducted in accordance with the regulations of the Helsinki Declaration.